HARVARD BIOSCIENCE INC
NASDAQ: HBIO (Harvard Bioscience, Inc.)
Last update: yesterday, 10:10PM2.71
-0.02 (-0.73%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Harvard Bioscience, Inc. | Mixed | Mixed |
Stockmoo Score
|
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Amh Equity Ltd | 30 Jun 2024 | 2,199,922 |
| Heartland Advisors Inc | 30 Jun 2024 | 1,200,000 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Sep 2024 | Announcement | Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference |
| 08 Aug 2024 | Announcement | Harvard Bioscience Announces Second Quarter 2024 Financial Results |
| 02 Aug 2024 | Announcement | Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |